Pfizer Settles BYU's Long-Running Celebrex Suit
By Bill Donahue ( May 1, 2012, 5:11 PM EDT) -- Pfizer Inc. said Tuesday that it has settled Brigham Young University's long-running contract and trade secrets lawsuit that claimed one of the school's professors discovered the enzyme behind the development of the drugmaker's anti-inflammatory drugs Bextra and Celebrex....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.